4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-014622
Chief Commercial Officer acquired 84,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cheng Sohanya Roshan Chief Commercial Officer | 2022-02-28 | Grant or award | +84,000 | 91,500 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cheng Sohanya Roshan Chief Commercial Officer | 2022-02-28 | Grant or award · Stock Option (right to buy) | +108,000 | 108,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…